COVID-19 drops to 10th leading cause of death as U.S. mortality rates fall in 2023

Provisional 2023 U.S. mortality data show COVID-19 as the 10th leading cause of death, with the highest overall mortality rates among non-Hispanic Black individuals.

Preparing for the Horizons: Perspectives on Psychedelics Event in New York | Psychedelic Invest

Horizons: Perspectives on Psychedelics stands as a beacon for those intrigued by the enigmatic world of psychedelic research and culture. As Horizons approaches its 16th

March 27, 2024

Eli Lilly’s Omvoh earns FDA approval for Crohn’s disease

The FDA approved Eli Lilly’s Omvoh in Crohn’s disease, the company announced Wednesday, handing the drug its second indication after giving it a green light

January 16, 2025

First Drug Approved for Niemann-Pick Disease Type C

The FDA on Friday approved arimoclomol (Miplyffa) as the first treatment specifically for the genetic disorder Niemann-Pick disease type C (NPC), an ultra-rare and progressive

September 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.